Skip to main navigation Skip to search Skip to main content

Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis.

Project: Research project

Project Details

Description

Project 2: Microenvironmental and inflammatory mechanisms in MDM4-driven AML pathogenesis. Project Leader: Ulrich Steidl Project Narrative We hypothesize that MDM4 overexpression acts in ARCH/MDS-to-AML progression in the context of microenvironmental changes and selection pressures that are frequently encountered during aging and inflammatory stress. Our studies will provide novel mechanistic insights into combinatorial cell-intrinsic/extrinsic preleukemic to AML progression as well as a preclinical proof- of-concept for the design of preventative clinical trials in the future.
StatusActive
Effective start/end date7/1/24 → 8/31/27

Funding

  • National Cancer Institute: $643,607.00
  • National Cancer Institute: $627,482.00
  • National Cancer Institute: $627,482.00

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.